Application of Receptor Theory to Allosteric Modulation of Receptors

被引:15
作者
Hall, David A. [1 ]
机构
[1] GlaxoSmithKline, Fibrosis DPU, Stevenage, Herts, England
来源
OLIGOMERIZATION AND ALLOSTERIC MODULATION IN G-PROTEIN COUPLED RECEPTORS | 2013年 / 115卷
关键词
MUSCARINIC RECEPTORS; OCCUPANCY MODEL; RADIOLIGAND BINDING; OPERATIONAL MODELS; PROTEAN AGONISM; 2-STATE MODEL; EFFICACY; ACETYLCHOLINE; ACTIVATION; AFFINITY;
D O I
10.1016/B978-0-12-394587-7.00006-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
In this chapter, three topics are considered. The allosteric two-state model (ATSM) is compared with explicit multiconformational models. This demonstrates that the ATSM encapsulates the common behaviors of any model with at least two active and two inactive conformations: the "states" of the model represent ensembles of active and inactive conformations. A matrix representation of multiconformational models is introduced to provide a compact notation for models with arbitrarily large numbers of conformations. Allosteric modulation is further explored in the context of an operational model of receptor activity which includes constitutive receptor activity. Fitting this model allows the apparent affinity, intrinsic efficacy, and cooperativity constants of a pair of allosteric ligands to be determined. It is also demonstrated that, within certain limits, it is possible to estimate the parameters of the ATSM. Finally, a novel operational model is developed that may allow the analysis of protean ligands. This model requires a nonlinear stimulus function and two parameters to define the efficacy of a ligand. Expressions describing competitive and allosteric interactions under this model are developed and the results of applying null analyses to the data are determined.
引用
收藏
页码:217 / 290
页数:74
相关论文
共 38 条
[1]
Balakrishnan V.K., 1997, Schaum's Outline of Graph Theory: Including Hundreds of Solved Problems. Schaum's Outline Series
[2]
Bindslev Niels, 2004, BMC Pharmacology, V4, P11, DOI 10.1186/1471-2210-4-11
[3]
OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[4]
G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[5]
Colquhoun D., 1973, Drug Receptors, P149, DOI DOI 10.1007/978-1-349-00910-7_11
[6]
Co-agonism in drug-receptor interaction: Illustrated by the NMDA receptors [J].
Corsi, M ;
Fina, P ;
Trist, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (06) :220-222
[7]
ANTAGONISTS WITH NEGATIVE INTRINSIC ACTIVITY AT DELTA-OPIOID RECEPTORS COUPLED TO GTP-BINDING PROTEINS [J].
COSTA, T ;
HERZ, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7321-7325
[8]
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[9]
EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
[10]
Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor [J].
Ehlert, Frederick J. ;
Griffin, Michael T. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (03) :1039-1060